Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DermaPro (DPOCl) for Non-Healing Diabetic Foot Ulcers
2020-003326-23Phase 3Terminated
- Sponsor
- DermaTools Biotech
- Start
- Nov 2020
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic foot ulcer (DFU) comparing DermaPro 1.2 mM with Vehicle solution (2 arms). Primary endpoint: Complete wound closure rate. Started Nov 2020; status: terminated.
02
Drugs
DermaPro
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on 2020-003326-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003326-23.